For: | Perisetti A, Goyal H, Yendala R, Chandan S, Tharian B, Thandassery RB. Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions. World J Gastroenterol 2022; 28(4): 432-448 [PMID: 35125828 DOI: 10.3748/wjg.v28.i4.432] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i4/432.htm |
Number | Citing Articles |
1 |
Zhengjie Lu, Xuefei Li, Yongjian Qi, Bin Li, Liaobin Chen. Genetic evidence of the causal relationship between chronic liver diseases and musculoskeletal disorders. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-04941-1
|
2 |
Ya-Ming Xie, Wenfeng Lu, Jian Cheng, Mugen Dai, Si-Yu Liu, Dong-Dong Wang, Tian-Wei Fu, Tai-Wei Ye, Jun-Wei Liu, Cheng-Wu Zhang, Dong-Sheng Huang, Lei Liang. Naples Prognostic Score is an Independent Prognostic Factor in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 1423 doi: 10.2147/JHC.S414789
|
3 |
Maxence Fulbert, Mehdi El Amrani, Clio Baillet, Katia Lecolle, Olivier Ernst, Alexandre Louvet, François-René Pruvot, Damien Huglo, Stéphanie Truant. Sarcopenia does not affect liver regeneration and postoperative course after a major hepatectomy. A prospective study on 125 patients using CT volumetry and HIDA scintigraphy. Clinics and Research in Hepatology and Gastroenterology 2024; 48(5): 102332 doi: 10.1016/j.clinre.2024.102332
|
4 |
Hyun Eom Jung, Dai Hoon Han, Bon-Nyeo Koo, Jeongmin Kim. Effect of sarcopenia on postoperative ICU admission and length of stay after hepatic resection for Klatskin tumor. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1136376
|
5 |
Fariha Ilyas, Fuad Zain Aloor, Sanjaya K. Satapathy. Sarcopenia and Frailty in Advanced Liver Disease Patients: A Comprehensive Review. Current Hepatology Reports 2024; 23(1): 88 doi: 10.1007/s11901-024-00640-z
|
6 |
Jian Xu, Zhi-Xiang Xu, Qi-Fan Yang, Jing Zhuang, Xin Zhu, Jun Yao. Association between the sarcopenia index and abnormal liver function in the adult population in the United States: a cross-sectional study. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1266253
|
7 |
Tarig Elhakim, Arian Mansur, Jordan Kondo, Omar Moustafa Fathy Omar, Khalid Ahmed, Azadeh Tabari, Allison Brea, Gabriel Ndakwah, Shams Iqbal, Andrew S. Allegretti, Florian J. Fintelmann, Eric Wehrenberg-Klee, Christopher Bridge, Dania Daye. Beyond MELD Score: Association of Machine Learning-derived CT Body Composition with 90-Day Mortality Post Transjugular Intrahepatic Portosystemic Shunt Placement. CardioVascular and Interventional Radiology 2024; 48(2): 221 doi: 10.1007/s00270-024-03886-8
|
8 |
Shakira Hoque, Christy Kim, Mihir Desai, Pram Sirimana, Malin Katarina Schumacher, Sri Jasti, Mostafa Abasseri, Oliver M.Fisher, Francis Chu, Suhrid Lodh, Natalie Collier, Winston Liauw, Piotr Milkiewicz, Amany Zekry. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; : 321 doi: 10.1002/9781119756422.ch18
|
9 |
Jelena Jadzic, Danijela Djonic. Hepatocellular carcinoma and musculoskeletal system: A narrative literature review. World Journal of Gastroenterology 2024; 30(15): 2109-2117 doi: 10.3748/wjg.v30.i15.2109
|
10 |
Fatima Al Zahra Yakti, Lana Abusalah, Vijay Ganji. Sarcopenia and Mortality in Critically Ill COVID-19 Patients. Life 2023; 14(1): 24 doi: 10.3390/life14010024
|
11 |
Leticia Macedo EIFLER, Thaís Rodrigues MOREIRA, João Pedro Pagani POSSEBON, Luis Fernando FERREIRA, Raquel de Freitas JOTZ, Ângelo Z MATTOS. IMPACT OF SARCOPENIA ON THE PROGNOSIS OF PATIENTS WITH CIRRHOSIS HOSPITALIZED FOR ACUTE DECOMPENSATION OR ACUTE-ON-CHRONIC LIVER FAILURE. Arquivos de Gastroenterologia 2024; 61 doi: 10.1590/s0004-2803.24612024-069
|
12 |
Camille Marcantei, Alexis Couret, James King, Simon Mazeaud, Abergel Armand, Gaël Ennequin. Effects of Exercise Training on Muscle Mass and Physical Function in Patients with Hepatocellular Carcinoma After Diagnosis: A Systematic Review. Digestive Diseases and Sciences 2024; 69(7): 2667 doi: 10.1007/s10620-024-08441-6
|
13 |
Shunsuke Doi, Satoshi Yasuda, Yasuko Matsuo, Takeshi Sakata, Satoshi Nishiwada, Minako Nagai, Kota Nakamura, Taichi Terai, Yuichiro Kohara, Masayuki Sho. Clinical impact of sarcopenia in early-stage intrahepatic recurrent hepatocellular carcinoma: an association with impaired host immunity. Langenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-03170-2
|
14 |
Maurizio Biselli, Nicola Reggidori, Massimo Iavarone, Matteo Renzulli, Lorenzo Lani, Alessandro Granito, Fabio Piscaglia, Stefania Lorenzini, Eleonora Alimenti, Giulio Vara, Paolo Caraceni, Angelo Sangiovanni, Massimo Marignani, Elia Gigante, Nicolò Brandi, Annagiulia Gramenzi, Franco Trevisani. Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib. Cancers 2024; 16(6): 1080 doi: 10.3390/cancers16061080
|
15 |
Annalisa Cespiati, Daniel Smith, Rosa Lombardi, Anna Ludovica Fracanzani. The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes. Cancers 2024; 16(13): 2315 doi: 10.3390/cancers16132315
|
16 |
Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, Yuka Ikeda, Tomoko Asai, Ai Tsuji, Satoru Matsuda. Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma. Exploration of Targeted Anti-tumor Therapy 2023; : 556 doi: 10.37349/etat.2023.00152
|
17 |
Aymen Bahsoun, Hero K. Hussain. The Missing Link: Sarcopenia’s Contribution to Long-term HCC Prognosis. Academic Radiology 2024; 31(4): 1284 doi: 10.1016/j.acra.2024.03.001
|
18 |
Yusheng Guo, Yanqiao Ren, Licheng Zhu, Lian Yang, Chuansheng Zheng. Association between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma: an updated meta-analysis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-022-27238-z
|
19 |
Alexandros Giakoustidis, Menelaos Papakonstantinou, Paraskevi Chatzikomnitsa, Areti Danai Gkaitatzi, Petros Bangeas, Panagiotis Dimitrios Loufopoulos, Eleni Louri, Athanasia Myriskou, Ioannis Moschos, Diomidis Antoniadis, Dimitrios Giakoustidis, Vasileios N. Papadopoulos. The Effects of Sarcopenia on Overall Survival and Postoperative Complications of Patients Undergoing Hepatic Resection for Primary or Metastatic Liver Cancer: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2024; 13(13): 3869 doi: 10.3390/jcm13133869
|
20 |
Michael Praktiknjo, Ana S. Pena Solano, Farsaneh Sadeghlar, Thomas Welchowski, Matthias Schmid, Christian Möhring, Taotao Zhou, Robert Mahn, Malte B. Monin, Carsten Meyer, Georg Feldmann, Peter Brossart, Cornelius van Beekum, Alexander Semaan, Hanno Matthaei, Steffen Manekeller, Alois M. Sprinkart, Sebastian Nowak, Julian Luetkens, Jörg C. Kalff, Christian P. Strassburg, Maria A. González-Carmona. The impact of lenvatinib on sarcopenia in patients with advanced unresectable hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-66766-8
|
21 |
Maha Elsabaawy, Hanaa Badran, Amr Ragab, Rasha Abdelwahab, Eman Sayed, Sameh Afify, Warda Othman. Appraisal of a newly developed ALBI-sarcopenia score as a prognostic marker in patients with hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2024; 36(7): 924 doi: 10.1097/MEG.0000000000002776
|
22 |
Bing Fu, Lei Hu, Hui Ji, Ya-Feng Hou. New research progress of sarcopenia in surgically resectable malignant tumor diseases. World Journal of Clinical Oncology 2025; 16(4): 100309 doi: 10.5306/wjco.v16.i4.100309
|
23 |
Francesca Campani, Tancredi Vincenzo Li Cavoli, Umberto Arena, Fabio Marra, Erica Nicola Lynch, Claudia Campani. Quick and easy assessment of sarcopenia in cirrhosis: Can ultrasound be the solution?. World Journal of Gastroenterology 2024; 30(17): 2287-2293 doi: 10.3748/wjg.v30.i17.2287
|
24 |
Jen-Fu Yang, Wen-Yen Huang, Cheng-Hsiang Lo, Meei-Shyuan Lee, Chun-Shu Lin, Po-Chien Shen, Yang-Hong Dai, Ying-Fu Wang, Teng-Wei Chen. Significant muscle loss after stereotactic body radiotherapy predicts worse survival in patients with hepatocellular carcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21443-6
|
25 |
Ruiqi Liu, Jiajun Wu, Haiwei Guo, Weiping Yao, Shuang Li, Yanwei Lu, Yongshi Jia, Xiaodong Liang, Jianming Tang, Haibo Zhang. Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets. MedComm 2023; 4(3) doi: 10.1002/mco2.292
|
26 |
Alexis Goffaux, Alicia Delorme, Géraldine Dahlqvist, Nicolas Lanthier. Improving the prognosis before and after liver transplantation: Is muscle a game changer?. World Journal of Gastroenterology 2022; 28(40): 5807-5817 doi: 10.3748/wjg.v28.i40.5807
|
27 |
Giorgio Esposto, Raffaele Borriello, Linda Galasso, Fabrizio Termite, Irene Mignini, Lucia Cerrito, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Ultrasound Evaluation of Sarcopenia in Patients with Hepatocellular Carcinoma: A Faster and Easier Way to Detect Patients at Risk. Diagnostics 2024; 14(4): 371 doi: 10.3390/diagnostics14040371
|
28 |
Kyoko Oura, Asahiro Morishita, Joji Tani, Takako Nomura, Takushi Manabe, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Takayuki Sanomura, Yoshihiro Nishiyama, Tsutomu Masaki. Prognostic Value of Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy. Cancers 2023; 15(6): 1834 doi: 10.3390/cancers15061834
|
29 |
Berend R. Beumer, Kosei Takagi, Stefan Buettner, Yuzo Umeda, Takahito Yagi, Toshiyoshi Fujiwara, Jeroen L.A. van Vugt, Jan N.M. IJzermans. Impact of sarcopenia on clinical outcomes for patients with resected hepatocellular carcinoma: a retrospective comparison of Eastern and Western cohorts. International Journal of Surgery 2023; 109(8): 2258 doi: 10.1097/JS9.0000000000000458
|
30 |
Claudio Trobiani, Nicolò Ubaldi, Leonardo Teodoli, Marcello Andrea Tipaldi, Federico Cappelli, Sara Ungania, Giulio Vallati. The Deterioration of Sarcopenia Post-Transarterial Radioembolization with Holmium-166 Serves as a Predictor for Disease Progression at 3 Months in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study. Journal of Personalized Medicine 2024; 14(5): 511 doi: 10.3390/jpm14050511
|
31 |
Yuji Morine, Yu Saito, Shinichiro Yamada, Hiroki Teraoku, Yuhei Waki, Takayuki Noma, Tetsuya Ikemoto, Mitsuo Shimada. Multiplication of tumor maximum diameter and number as a new surgical indicator for Barcelona Clinic Liver Cancer intermediate‐stage hepatocellular carcinoma. Hepatology Research 2023; 53(6): 531 doi: 10.1111/hepr.13887
|
32 |
Ariel Jaffe, Tamar H. Taddei, Edoardo G. Giannini, Ysabel C. Ilagan‐Ying, Massimo Colombo, Mario Strazzabosco. Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook. Liver International 2022; 42(12): 2607 doi: 10.1111/liv.15432
|
33 |
Bernhard Scheiner, Katharina Lampichler, Katharina Pomej, Lucian Beer, Lorenz Balcar, Riccardo Sartoris, Mohamed Bouattour, Sabrina Sidali, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Martina Scharitzer, Dietmar Tamandl, David J. Pinato, Maxime Ronot, Matthias Pinter. Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapy. Hepatology Communications 2023; 7(10) doi: 10.1097/HC9.0000000000000261
|
34 |
Lorenzo Bernardi, Raffaello Roesel, Filippo Vagelli, Pietro Majno-Hurst, Alessandra Cristaudi. Imaging based body composition profiling and outcomes after oncologic liver surgery. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1007771
|
35 |
Lampros Chrysavgis, Magdalini Adamantou, Anna Angelousi, Evangelos Cholongitas. The association of testosterone with sarcopenia and frailty in chronic liver disease. European Journal of Clinical Investigation 2024; 54(2) doi: 10.1111/eci.14108
|
36 |
Pompilia Radu, Maryam Ebadi, Aldo J. Montano-Loza, Jean Francois Dufour. What Is the Role of Body Composition Assessment in HCC Management?. Cancers 2022; 14(21): 5290 doi: 10.3390/cancers14215290
|
37 |
Carlos Constantin Otto, Guanwu Wang, Anna Mantas, Daniel Heise, Philipp Bruners, Sven Arke Lang, Tom Florian Ulmer, Ulf Peter Neumann, Lara Rosaline Heij, Jan Bednarsch. Time to surgery is not an oncological risk factor in HCC patients undergoing liver resection. Langenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-02922-4
|
38 |
Maria Stella Franzè, Paul Vigneron, Anna Sessa, Carlo Saitta, Julia Chalaye, Vania Tacher, Alain Luciani, Hélène Regnault, Ancuta Bejan, Rami Rhaiem, Daniele Sommacale, Vincent Leroy, Raffaele Brustia, Giovanni Raimondo, Giuliana Amaddeo. Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy. Annals of Hepatology 2025; 30(1): 101539 doi: 10.1016/j.aohep.2024.101539
|
39 |
Atsushi Nakamura, Takeshi Ichikawa, Hitoshi Asakura. Diagnosis and pathological analysis of sarcopenia in chronic liver disease using liver MRI. Kanzo 2022; 63(7): 305 doi: 10.2957/kanzo.63.305
|
40 |
Chuan Jiang, Yanyan Wang, Wei Fu, Guozhuan Zhang, Xiaoshan Feng, Xing Wang, Fang Wang, Le Zhang, Yang Deng. Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.978110
|
41 |
Xi-yue Zhang, Ming Luo, Shu Qin, Wen-guang Fu, Meng-yu Zhang. FXR, MRP-1 and SLC7A5: New Targets for the Treatment of Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2024; 23 doi: 10.1177/15330338241276889
|
42 |
Yasuyuki Tamai, Motoh Iwasa, Akiko Eguchi, Ryuta Shigefuku, Ryosuke Sugimoto, Hideaki Tanaka, Yoshinao Kobayashi, Shugo Mizuno, Hayato Nakagawa. The prognostic role of controlling nutritional status and skeletal muscle mass in patients with hepatocellular carcinoma after curative treatment. European Journal of Gastroenterology & Hepatology 2022; 34(12): 1269 doi: 10.1097/MEG.0000000000002459
|
43 |
Andrea Dalbeni, Leonardo Antonio Natola, Marta Garbin, Mirko Zoncapè, Filippo Cattazzo, Anna Mantovani, Antonio Vella, Stefania Canè, Jasmin Kassem, Michele Bevilacqua, Simone Conci, Tommaso Campagnaro, Andrea Ruzzenente, Alessandra Auriemma, Alessandro Drudi, Giovanna Zanoni, Alfredo Guglielmi, Michele Milella, David Sacerdoti. Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients. Cancers 2023; 15(9): 2406 doi: 10.3390/cancers15092406
|
44 |
Qiang Wang, Anrong Wang, Zhen Li, Ernesto Sparrelid, Torkel B. Brismar. Impact of sarcopenia on the future liver remnant growth after portal vein embolization and associating liver partition and portal vein ligation for staged hepatectomy in patients with liver cancer: A systematic review. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1064785
|
45 |
Meng-Hsuan Kuo, Chih-Wei Tseng, Ching-Sheng Hsu, Yen-Chun Chen, I-Ting Kao, Chen-Yi Wu, Shih-Chieh Shao. Prevalence and Effect of Low Skeletal Muscle Mass among Hepatocellular Carcinoma Patients Undergoing Systemic Therapy: A Systematic Review and Meta-Analysis. Cancers 2023; 15(9): 2426 doi: 10.3390/cancers15092426
|
46 |
Shunsuke Doi, Satoshi Yasuda, Miu Miyashita, Minako Nagai, Kota Nakamura, Yasuko Matsuo, Taichi Terai, Yuichiro Kohara, Takeshi Sakata, Masayuki Sho. Prognostic relevance of sarcopenia and tumor‐infiltrating CD8+ T cells in patients with hepatocellular carcinoma. Annals of Gastroenterological Surgery 2025; 9(2): 359 doi: 10.1002/ags3.12875
|
47 |
Kyoko Oura, Asahiro Morishita, Takushi Manabe, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Joji Tani, Masafumi Ono, Chikara Ogawa, Akio Moriya, Tomonori Senoo, Akemi Tsutsui, Takuya Nagano, Koichi Takaguchi, Takashi Himoto, Tsutomu Masaki. Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy. Cancers 2023; 15(12): 3243 doi: 10.3390/cancers15123243
|
48 |
Na Qiang, Junjie Ao, Masato Nakamura, Keichi Katayama, Jiaqi Zhang, Tadayoshi Kogure, Keita Ogawa, Hiroaki Kanzaki, Ryuta Kojima, Keisuke Koroki, Kazufumi Kobayashi, Masanori Inoue, Naoya Kanogawa, Soichiro Kiyono, Ryo Nakagawa, Takayuki Kondo, Sadahisa Ogasawara, Shingo Nakamoto, Ryosuke Muroyama, Jun Kato, Naoya Kato. MEGF6 knockdown ameliorates lenvatinib-induced muscle differentiation suppression and enhances the antitumor effect of lenvatinib on hepatocellular carcinoma. Biochemical Pharmacology 2025; 235: 116829 doi: 10.1016/j.bcp.2025.116829
|